About 40 million people suffer from lactose intolerance in America. If Ritter Pharmaceuticals Inc. (RTTR) has any say, that number will soon be zero.
CEO Andrew Ritter told TheStreet at the LD Micro conference in Los Angeles that his company is getting closer to developing a treatment for lactose intolerance. If successful, it could serve as a one-time treatment that will end the symptoms for the millions who are forced to avoid dairy or face dire consequences.
For more from the LD Micro Conference in La: